Leading global IT services provider, HCL Technologies Ltd. (HCL), on Tuesday announced that it has won a contract from US-based beverages producer Dr Pepper Snapple Group (DPS) to provide IT application support and infrastructure management services.

As per the agreement, HCL will deliver application support to DPS and manage and monitor its infrastructure for a period of five years.

Apart from this, the Indian IT firm will also deliver managed print services to DPS under the contract.

Biocon Limited launched a new drug for treatment of diabetes. The new drug known as 'Basalog' can treat patients suffering from both type one and type two diabetes.

Biocon's Kiran Mazumdar-Shaw said that the key advantage of Basalog is that it replaces other insulins that do not act for 24 hours requiring a diabetic to take multiple shots in a day. Basalog could be used just once in a day.